Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bluetooth Device Enables Remote Glucose Monitoring

By HospiMedica International staff writers
Posted on 21 Oct 2014
A novel diabetes management platform can sync readings from over 30 blood glucose meters to supported Apple and Android devices.

The Glooko MeterSync Blue is a software as a service (SaaS) remote monitoring and population management platform that uses Bluetooth technology to provide health systems and payer groups the ability to more cost-effectively enroll diabetes patients into remote monitoring programs. More...
With the MeterSync Blue, patients do not need to switch to costly, wireless-enabled, blood glucose meters developed specifically for telemedicine. Instead, health systems and payer groups can leverage the tens of millions of meters already deployed to patients worldwide.

The MeterSync Blue facilitates remote monitoring via the Glooko Population Tracker, which delivers pattern recognition algorithms and flags for care managers to easily identify patients experiencing potentially harmful amounts of hyperglycemic or hypoglycemic events in between clinic visits. By allowing patients to wirelessly sync their blood glucose reading after testing, the device opens the door for Glooko, in collaboration with health systems and payers, to deliver more real-time reminders and recommendations to patients with diabetes.

Cloud-based technology, mobile apps, and the MyGlooko secure web view allow users to email, print, or fax standardized reports to the healthcare team, including blood glucose averages, statistics, and graphs. The SaaS also hosts a food database with over 200,000 items from popular restaurants and grocery stores, and also integrates with popular food apps. Carbohydrate intake is chronologically associated with blood glucose data for better pattern recognition. The Glooko MeterSync Blue and apps are products of Glooko (Palo Alto, CA, USA).

“I am looking forward to using Glooko MeterSync Blue, which should make the platform more valuable by ensuring that patients can more seamlessly share their data with me between visits, particularly those at higher risk, including women during pregnancy and poorly controlled patients initiating treatment with insulin,” said endocrinologist Prof. Zachary Bloomgarden, MD, of Mt. Sinai Medical Center (New York, NY, USA). “It should also help with patients who are not at high risk but for whom the ability to review home glucose monitoring results will improve adherence to the increasingly complex regimens of modern diabetes management.”

Related Links:

Glooko 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.